ACGN insider filings

Aceragen, Inc. — 19 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-08-11. Screen ACGN transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for ACGN between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Aceragen, Inc.

FiledFormInsiderReported transactionsSource
2023-08-114GOWEN MAXINE — DirectorSale (S): 51 @ $0.51EDGAR
2023-08-114MILANO VINCENT — DirectorSale (S): 3,283 @ $0.53EDGAR
2023-07-194Pillar Invest Corp — 10% owner
Pillar Partners Foundation, L.P. — 10% owner
Pillar Pharmaceuticals 6, L.P. — 10% owner
Umari Abude — 10% owner
ZEIN YOUSSEF EL — 10% owner
Purchase (P): 26,965 @ $1.42EDGAR
2023-07-194Pillar Invest Corp — 10% owner
Pillar Partners Foundation, L.P. — 10% owner
Pillar Pharmaceuticals 6, L.P. — 10% owner
Umari Abude — 10% owner
ZEIN YOUSSEF EL — 10% owner
Sale (S): 3,605 @ $1.58 · Sale (S): 2,213 @ $1.54EDGAR
2023-05-184Chopra Atul — 10% ownerSale (S): 6,887 @ $1.40 · Sale (S): 6,645 @ $1.41 · Sale (S): 8,469 @ $1.42 · Sale (S): 1,220 @ $1.43 · Sale (S): 3,369 @ $1.44 · Sale (S): 701 @ $1.45 · +19 moreEDGAR
2023-05-184Chopra Atul — 10% ownerSale (S): 23,890 @ $1.50 · Sale (S): 7,162 @ $1.51 · Sale (S): 4,676 @ $1.52 · Sale (S): 6,310 @ $1.53 · Sale (S): 3,199 @ $1.54 · Sale (S): 2,075 @ $1.55 · +15 moreEDGAR
2023-05-184Chopra Atul — 10% ownerSale (S): 3,734 @ $1.75 · Sale (S): 50 @ $1.76 · Sale (S): 81 @ $1.77 · Sale (S): 5,737 @ $1.78 · Sale (S): 4,151 @ $1.79 · Sale (S): 3,301 @ $1.80 · +14 moreEDGAR
2023-02-024Taylor John Clayton — CHIEF EXECUTIVE OFFICER, DirectorGrant/award (A): 74,500 (derivative) @ $0EDGAR
2023-02-024Kraus Carl N — CHIEF MEDICAL OFFICERGrant/award (A): 25,400 (derivative) @ $0EDGAR
2023-02-024Salain Daniel — CHIEF OPERATING OFFICERGrant/award (A): 25,400 (derivative) @ $0EDGAR
2023-02-024Lim Bryant David — SVP AND GENERAL COUNSELGrant/award (A): 25,400 (derivative) @ $0EDGAR
2023-02-024Kirby John J. — CHIEF FINANCIAL OFFICERGrant/award (A): 25,400 (derivative) @ $0EDGAR
2023-02-024JORDAN ANDREW R — CHIEF STRATEGY OFFICERGrant/award (A): 25,400 (derivative) @ $0EDGAR
2023-01-194Taylor John Clayton — Chief Executive Officer, DirectorOption exercise (M): 1,341,764 · Option exercise (M): 22,810 (derivative)EDGAR
2023-01-194Kraus Carl N — Chief Medical OfficerOption exercise (M): 440,844 (derivative)EDGAR
2023-01-194Salain Daniel — Chief Operating OfficerOption exercise (M): 1,341,764 · Option exercise (M): 22,810 (derivative)EDGAR
2023-01-194WOOTEN RONALD J — DirectorConversion (C): 14,115 (derivative) · Conversion (C): 830,294 (derivative)EDGAR
2023-01-194JORDAN ANDREW R — Chief Strategy OfficerOption exercise (M): 402,529 · Option exercise (M): 6,843 (derivative)EDGAR
2023-01-184NovaQuest Co-Investment Fund XV, L.P. — Director
NQ POF V GP, Ltd. — Director
Conversion (C): 14,115 (derivative) · Conversion (C): 830,294 (derivative)EDGAR

Recent 8-K events — Aceragen, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2023-08-168-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-07-218-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2023-07-118-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-05-308-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
9.01 — Financial Statements and Exhibits
EDGAR
2023-05-048-K?
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
EDGAR
2023-03-308-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2023-02-068-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-02-038-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2023-01-188-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-01-178-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ACGN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs